Biodesix Income Statement (2019-2026) | BDSX

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
11.88M6.53M7.22M6.55M10.95M11.11M9.61M9.06M11.87M13.49M14.67M14.82M17.93M18.15M20.43M17.96M20.02M21.77M28.75M25.55M
Cost of Revenue (Quarter)
7.08M2.72M2.49M3.23M3.98M3.63M3.31M3.17M3.24M3.23M3.37M2.15M3.88M4.18M-3.66M3.70M4.03M4.11M1.96M4.21M
Gross Profit (Quarter)
4.80M3.81M4.73M3.31M6.97M7.47M6.30M5.89M8.63M10.26M11.29M12.67M14.05M13.97M24.09M14.26M15.99M17.66M26.79M21.35M
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)
3.32M3.29M2.85M3.21M3.36M2.97M3.56M3.25M2.91M1.94M1.89M2.04M2.56M2.55M2.41M2.87M3.27M2.99M2.87M3.29M
Selling, General & Administrative (Quarter)
11.43M13.61M13.56M14.49M15.23M15.11M16.63M18.99M16.65M15.50M16.25M20.56M19.66M20.02M20.22M20.45M22.41M21.71M22.97M24.26M
Other Operating Expenses (Quarter)
7.72M2.72M2.49M3.32M3.98M3.63M3.31M3.19M3.24M3.23M3.40M-21.00M3.94M-21.15M77.98M3.78M4.06M4.11M-23.91M4.21M
Operating Expenses (Quarter)
22.47M19.62M18.90M21.01M22.58M21.72M23.50M25.43M22.80M20.66M21.54M1.60M26.16M1.41M100.61M27.09M29.74M28.82M1.93M31.76M
Operating Income (Quarter)
-10.59M-13.09M-11.68M-14.46M-11.63M-10.61M-13.89M-16.37M-10.93M-7.17M-6.87M-11.02M-8.24M-8.59M-6.65M-9.14M-9.72M-7.05M-1.97M-6.20M
EBIT (Quarter)
-10.59M-13.09M-11.68M-14.46M-11.63M-10.61M-13.89M-16.37M-10.93M-7.17M-6.87M-11.02M-8.24M-8.59M-6.65M-9.14M-9.72M-7.05M-1.97M-6.20M
Non-operating items
Other Non Operating Income (Quarter)
-0.81M3.12M-1.60M0.01M-4.20M-3.09M-0.40M0.00M0.00M0.00M0.00M-0.06M-0.39M0.37M0.32M0.10M0.05M0.41M0.05M0.39M
Non Operating Income (Quarter)
-0.81M1.58M-1.60M-1.12M-4.20M-3.09M-6.45M-2.33M-2.43M0.00M-10.81M-2.59M-0.39M-1.67M-8.36M0.10M-1.75M-1.67M-2.01M-1.59M
Net income details
EBT (Quarter)
-11.40M-14.64M-13.18M-15.60M-12.97M-13.65M-16.44M-18.76M-13.36M-9.56M-9.20M-13.55M-10.17M-10.63M-8.40M-10.82M-11.62M-9.12M-4.03M-8.18M
Profit After Tax (Quarter)
-11.40M-11.51M-13.28M-15.59M-15.82M-13.70M-20.34M-18.70M-13.36M-10.95M-9.09M-13.61M-10.81M-10.26M-8.25M-11.10M-11.47M-8.72M-3.98M-7.79M
Income from Continuing Operations (Quarter)
-11.40M-14.64M-13.18M-15.60M-12.97M-13.65M-16.44M-18.76M-13.36M-9.56M-9.20M-13.55M-10.17M-10.63M-8.40M-10.82M-11.62M-9.12M-4.03M-8.18M
Consolidated Net Income (Quarter)
-11.40M-14.64M-13.18M-15.60M-12.97M-13.65M-16.44M-18.76M-13.36M-9.56M-9.20M-13.55M-10.17M-10.63M-8.40M-10.82M-11.62M-9.12M-4.03M-8.18M
Income towards Parent Company (Quarter)
-11.40M-14.64M-13.18M-15.60M-12.97M-13.65M-16.44M-18.76M-13.36M-9.56M-9.20M-13.55M-10.17M-10.63M-8.40M-10.82M-11.62M-9.12M-4.03M-8.18M
Net Income towards Common Stockholders (Quarter)
-11.40M-14.64M-13.18M-15.60M-12.97M-13.65M-16.44M-18.76M-13.36M-9.56M-9.20M-13.55M-10.17M-10.63M-8.40M-10.82M-11.62M-9.12M-4.03M-8.18M
Additional items
EPS (Basic) (Quarter)
-0.41-0.41-0.49-0.50-0.40-0.34-0.33-0.24-0.17-0.14-0.09-0.14-0.08-1.40-1.03-1.52-0.08-1.16-0.43-0.81
EPS (Weighted Average and Diluted) (Quarter)
-4.52-0.41-0.49-0.50-0.40-0.34-0.33-0.24-0.17-0.14-0.09-0.14-0.08-1.40-1.03-1.52-0.08-1.16-0.43-0.81
Shares Outstanding (Weighted Average) (Quarter)
2.52M27.47M27.36M31.07M39.24M40.45M42.10M77.77M78.51M78.67M82.11M97.17M112.17M6.18M6.47M7.30M146.33M7.50M7.55M9.66M
Shares Outstanding (Diluted Average) (Quarter)
2.52M27.47M27.36M31.07M39.24M40.45M42.10M77.77M78.14M78.67M82.11M97.17M127.17M7.32M6.47M7.30M146.66M7.50M7.55M9.66M
EBITDA (Quarter)
-10.59M-13.09M-11.68M-14.46M-11.63M-10.61M-13.89M-16.37M-10.93M-7.17M-6.87M-11.02M-8.24M-8.59M-6.65M-9.14M-9.72M-7.05M-1.97M-6.20M
Interest Expenses (Quarter)
0.81M1.55M1.50M1.14M1.35M3.04M2.55M2.39M2.43M2.39M2.33M2.53M1.94M2.04M1.75M1.69M1.90M2.07M2.06M1.98M